(R)-(-)-10-Methyl-11-hydroxyaporphine: A Highly Selective Serotonergic Agonist

Joseph G. Cannon, Prem Mohan, Jacek Bojarski, John Paul Long, Ranbir K. Bhatnagar, Paul A. Leonard, Jan R. Flynn, Tapan K. Chatterjee

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


Prior work in these laboratories identified (±)-5-hydroxy-6-methyl-2-(di-n-propylamino)tetralin as a dopaminergic agonist prodrug. The ortho methyl hydroxy aromatic substitution pattern in this molecule has now been incorporated into the aporphine ring system to give a congener of the dopaminergic agonist apomorphine in which the position 10 OH group has been replaced by methyl. Preparation of the target compound involved acid-catalyzed rearrangement of the 3-(1-phenyltetrazolyl) ether of morphine and subsequent molecular modification of the product, the 10-(1-phenyltetrazolyl) ether of (R)-(-)-apomorphine. Surprisingly, the target compound elicited no responses in any assays for effects at dopamine receptors, but rather it displayed pharmacological properties consistent with its being a serotonergic agonist with a high degree of selectivity for 5-HT1A receptors similar to the serotonergic agonist 8-hydroxy-2-(di-n-propylamino)tetralin.

Original languageEnglish (US)
Pages (from-to)313-318
Number of pages6
JournalJournal of Medicinal Chemistry
Issue number2
StatePublished - Dec 1 1988

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of '(R)-(-)-10-Methyl-11-hydroxyaporphine: A Highly Selective Serotonergic Agonist'. Together they form a unique fingerprint.

Cite this